![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
Reset all filters
01 8Janssen Inc.
02 16Purdue Pharma
03 1Blank
Reset all filters
01 11222950
02 42264852
03 82355644
04 82355854
05 42515884
Reset all filters
01 4Methylphenidate hydrochloride
02 20methylphenidate hydrochloride
03 1Blank
Reset all filters
01 16Controlled-Release Capsule
02 8Extended Release Tablet
03 1Blank
Reset all filters
01 12004-06-16
02 82017-09-16
03 162019-12-17
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Brand Name : CONCERTA
Patent Number : 2264852
Filing Date : 1997-09-16
Strength per Unit : 18mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Brand Name : CONCERTA
Patent Number : 2264852
Filing Date : 1997-09-16
Strength per Unit : 27mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Brand Name : CONCERTA
Patent Number : 2264852
Filing Date : 1997-09-16
Strength per Unit : 36mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Brand Name : CONCERTA
Patent Number : 2264852
Filing Date : 1997-09-16
Strength per Unit : 54mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2005-11-01
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Brand Name : CONCERTA
Patent Number : 2515884
Filing Date : 1997-09-16
Strength per Unit : 18mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Brand Name : CONCERTA
Patent Number : 2515884
Filing Date : 1997-09-16
Strength per Unit : 27mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Brand Name : CONCERTA
Patent Number : 2515884
Filing Date : 1997-09-16
Strength per Unit : 36mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Brand Name : CONCERTA
Patent Number : 2515884
Filing Date : 1997-09-16
Strength per Unit : 54mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-09-16
Date Granted : 2016-10-18
Patent Expiration Date : 2019-12-17
Date Granted : 2008-02-12
Brand Name : BIPHENTIN
Patent Number : 2355854
Filing Date : 1999-12-17
Strength per Unit : 50 mg
Dosage Form : Controlled-Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-12-17
Date Granted : 2008-02-12
Patent Expiration Date : 2019-12-17
Date Granted : 2008-02-12
Brand Name : BIPHENTIN
Patent Number : 2355854
Filing Date : 1999-12-17
Strength per Unit : 60 mg
Dosage Form : Controlled-Release Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-12-17
Date Granted : 2008-02-12
LOOKING FOR A SUPPLIER?